by Donald G. McNeill Jr.
The New York Times, 7 October 2017
In Africa, even the most treatable cancers can be a death sentence. The disease takes 450,000 lives annually. Working with the American Cancer Society, pharma giants Pfizer and Cipla agreed to slash the cost of cancer medications in Africa, where the WHO says the death toll could reach 1 million a year by 2030. To start, 6 countries will receive certain pills at 50 cents a pop, and infusions as low as US$ 10 – just above manufacturing cost. American oncologists and IBM are also bringing simple online treatment guidelines to under-resourced hospitals.